Antineoplaston A10 and AS2-1 compares favorably to radiation therapy and chemotherapy in patients with recurrent diffuse intrinsic brain stem glioma.

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.